Tobira Therapeutics (TBRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TBRA | HLVX | CVAC | ||
| Company | Tobira Therapeutics | Hillevax Inc | Curevac N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 41.83 | 15.62 | 3.62 | ||
| High | 42.33 | 16.05 | 3.98 | ||
| Low | 40.39 | 15.50 | 3.41 | ||
| Last | 42.09 | 15.84 | 3.49 | ||
| Change | +0.27 | +0.27 | +0.01 | ||
| % Change | +0.65% | +1.73% | +0.29% | ||
| Volume | 521,800 | 112,700 | 2,390,000 | ||
| 20-Day Average Volume | 230,795 | 156,260 | 756,830 | ||
| Previous Close | 41.82 | 15.57 | 3.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 40.68 | 13.66 | 2.84 | ||
| 20-Day Raw Stochastic | 91.81% | 89.70% | 72.24% | ||
| 20-Day Relative Strength | 87.55% | 58.28% | 63.08% | ||
| Weighted Alpha | +35.00 | -0.49 | -58.46 | ||
| Today's Opinion | N/A | 40% Buy | 40% Sell | ||
| Previous Opinion | N/A | 40% Buy | 40% Sell | ||
| Last Month's Opinion | N/A | 24% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.42% since 10/24/16 | +14.45% since 05/10/24 | +19.93% since 05/10/24 | ||
| Low | 40.39 on 10/31/16 | 13.08 on 05/14/24 | 2.90 on 05/13/24 | ||
| High | 42.33 on 10/31/16 | 16.31 on 05/16/24 | 3.98 on 05/17/24 | ||
| 1-Month | |||||
| %Chg | +5.91% since 09/30/16 | +26.42% since 04/17/24 | +35.80% since 04/17/24 | ||
| Low | 39.40 on 10/04/16 | 11.73 on 04/19/24 | 2.21 on 04/25/24 | ||
| High | 42.33 on 10/31/16 | 16.31 on 05/16/24 | 3.98 on 05/17/24 | ||
| 3-Month | |||||
| %Chg | +876.57% since 07/29/16 | +3.33% since 02/16/24 | +1.75% since 02/16/24 | ||
| Low | 3.76 on 08/02/16 | 11.73 on 04/19/24 | 2.21 on 04/25/24 | ||
| High | 42.33 on 10/31/16 | 20.22 on 03/04/24 | 3.98 on 05/17/24 | ||
| 6-Month | |||||
| %Chg | +434.82% since 04/29/16 | +16.64% since 11/17/23 | -37.57% since 11/17/23 | ||
| Low | 3.76 on 08/02/16 | 11.73 on 04/19/24 | 2.21 on 04/25/24 | ||
| High | 42.33 on 10/31/16 | 20.22 on 03/04/24 | 6.30 on 12/15/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 787,090 | 787,581 | 781,341 | ||
| Shares Outstanding, K | 18,820 | 49,721 | 223,880 | ||
| Annual Sales | 0 | 0 | 58,180,000 | ||
| Annual Net Income | -49,620,000 | -123,570,000 | -281,580,000 | ||
| Last Quarter Sales | 1,060,000 | 0 | 24,330,000 | ||
| Last Quarter Net Income | -13,340,000 | -46,830,000 | -93,450,000 | ||
| 60-Month Beta | -2.81 | 0.79 | 2.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.97 on 05/09/24 | -0.42 on 04/24/24 | ||
| Latest Earnings Date | 11/08/16 | 05/10/24 | 06/04/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||